SCHEMBL7601747

SCHEMBL7601747

Fc1c(C(F)(F)F)cccc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 3/20 0.46
IDO1 P14902 2/20 0.44
TDO2 P48775 1/20 0.44
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
AXL P30530 1/20 0.40
KIF11 P52732 1/20 0.40
HSD11B1 P28845 1/20 0.39
P2RX7 Q99572 1/20 0.39
CES1 P23141 1/20 0.39
HCAR1 Q9BXC0 1/20 0.39
NOTUM Q6P988 1/20 0.39
MAPK1 P28482 1/20 0.39
EPHX2 P34913 1/20 0.39
KAT6A Q92794 1/20 0.39
CA2 P00918 1/20 0.38
CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12251347 0.87 CA2 (0.46) MPLIDO1TDO2ALDH1A1TSHR
SCHEMBL11613092 0.87 MPL (0.40) MPLIDO1TDO2ALDH1A1TSHR
SCHEMBL448487 0.86 HSD11B1 (0.47) MPLIDO1TDO2ALDH1A1POLB
SCHEMBL29551965 0.86 HSD11B1 (0.47) MPLIDO1TDO2ALDH1A1POLB
SCHEMBL28918929 0.84 IDO1 (0.43) MPLIDO1TDO2ALDH1A1POLB
SCHEMBL476648 0.82 MPL (0.40) MPLIDO1TDO2ALDH1A1POLB
SCHEMBL156730 0.82 MPL (0.47) MPLIDO1TDO2ALDH1A1TSHR
SCHEMBL2458716 0.82 MPL (0.40) MPLIDO1TDO2ALDH1A1POLB
SCHEMBL1125329 0.82 HSD17B1 (0.41) MPLIDO1TDO2ALDH1A1TSHR
SCHEMBL476650 0.82 MPL (0.44) MPLIDO1TDO2KIF11HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020042541-A1 Process for producing bis( trifluoromethyl)benzaldehyde CENTRAL GLASS COMPANY, LIMITED (JP) 2002-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042541-A1 Process for producing bis( trifluoromethyl)benzaldehyde BRPF1, PFAS, FLI1 MPL 1410/4885IDO1 521/4885TDO2 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.